Literature DB >> 24432257

The use of computational models to predict response to HIV therapy for clinical cases in Romania.

Andrew D Revell1, Luminiţa Ene2, Dan Duiculescu3, Dechao Wang1, Mike Youle4, Anton Pozniak5, Julio Montaner6, Brendan A Larder1.   

Abstract

INTRODUCTION: A major challenge in Romania is the optimisation of antiretroviral therapy for the many HIV-infected adults with, on average, a decade of treatment experience. The RDI has developed computational models that predict virological response to therapy but these require a genotype, which is not routinely available in Romania. Moreover the models, which were trained without any Romanian data, have proved most accurate for patients from the healthcare settings that contributed the training data. Here we develop and test a novel model that does not require a genotype, with test data from Romania.
METHODS: A random forest (RF) model was developed to predict the probability of the HIV viral load (VL) being reduced to <50 copies/ml following therapy change. The input variables were baseline VL, CD4 count, treatment history and time to follow-up. The model was developed with 3188 treatment changes episodes (TCEs) from North America, Western Europe and Australia. The model's predictions for 100 independent TCEs from the RDI database were compared to those of a model trained with the same data plus genotypes and then tested using 39 TCEs from Romania in terms of the area under the ROC curve (AUC).
RESULTS: When tested with the 100 independent RDI TCEs, the AUC values for the models with and without genotypes were 0.88 and 0.86 respectively. For the 39 Romanian TCEs the AUC was 0.60. However, when 14 cases with viral loads that may have been between 50 and 400 copies were removed, the AUC increased to 0.83. DISCUSSION: Despite having been trained without data from Romania, the model predicted treatment responses in treatment-experienced Romanian patients with clade F virus accurately without the need for a genotype. The results suggest that this approach might be generalisable and useful in helping design optimal salvage regimens for treatment-experienced patients in countries with limited resources where genotyping is not always available.

Entities:  

Keywords:  HIV; computational models; treatment response prediction

Year:  2012        PMID: 24432257      PMCID: PMC3882835          DOI: 10.11599/germs.2012.1007

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  11 in total

1.  The development of artificial neural networks to predict virological response to combination HIV therapy.

Authors:  Brendan Larder; Dechao Wang; Andrew Revell; Julio Montaner; Richard Harrigan; Frank De Wolf; Joep Lange; Scott Wegner; Lidia Ruiz; Maria Jésus Pérez-Elías; Sean Emery; Jose Gatell; Antonella D'Arminio Monforte; Carlo Torti; Maurizio Zazzi; Clifford Lane
Journal:  Antivir Ther       Date:  2007

2.  A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.

Authors:  Dechao Wang; Brendan Larder; Andrew Revell; Julio Montaner; Richard Harrigan; Frank De Wolf; Joep Lange; Scott Wegner; Lidia Ruiz; María Jésus Pérez-Elías; Sean Emery; Jose Gatell; Antonella D'Arminio Monforte; Carlo Torti; Maurizio Zazzi; Clifford Lane
Journal:  Artif Intell Med       Date:  2009-06-12       Impact factor: 5.326

3.  The development of an expert system to predict virological response to HIV therapy as part of an online treatment support tool.

Authors:  Andrew D Revell; Dechao Wang; Mark A Boyd; Sean Emery; Anton L Pozniak; Frank De Wolf; Richard Harrigan; Julio S G Montaner; Clifford Lane; Brendan A Larder
Journal:  AIDS       Date:  2011-09-24       Impact factor: 4.177

4.  Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance.

Authors:  Andrea De Luca; Antonella Cingolani; Simona Di Giambenedetto; Maria Paola Trotta; Francesco Baldini; Maria Gabriella Rizzo; Ada Bertoli; Giuseppina Liuzzi; Pasquale Narciso; Rita Murri; Adriana Ammassari; Carlo Federico Perno; Andrea Antinori
Journal:  J Infect Dis       Date:  2003-05-22       Impact factor: 5.226

5.  Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.

Authors:  Melanie A Thompson; Judith A Aberg; Pedro Cahn; Julio S G Montaner; Giuliano Rizzardini; Amalio Telenti; José M Gatell; Huldrych F Günthard; Scott M Hammer; Martin S Hirsch; Donna M Jacobsen; Peter Reiss; Douglas D Richman; Paul A Volberding; Patrick Yeni; Robert T Schooley
Journal:  JAMA       Date:  2010-07-21       Impact factor: 56.272

6.  Web resources for HIV type 1 genotypic-resistance test interpretation.

Authors:  Tommy F Liu; Robert W Shafer
Journal:  Clin Infect Dis       Date:  2006-04-28       Impact factor: 9.079

7.  Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time.

Authors:  Dineke Frentz; Charles A B Boucher; Matthias Assel; Andrea De Luca; Massimiliano Fabbiani; Francesca Incardona; Pieter Libin; Nino Manca; Viktor Müller; Breanndán O Nualláin; Roger Paredes; Mattia Prosperi; Eugenia Quiros-Roldan; Lidia Ruiz; Peter M A Sloot; Carlo Torti; Anne-Mieke Vandamme; Kristel Van Laethem; Maurizio Zazzi; David A M C van de Vijver
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

8.  Comparison between rules-based human immunodeficiency virus type 1 genotype interpretations and real or virtual phenotype: concordance analysis and correlation with clinical outcome in heavily treated patients.

Authors:  Carlo Torti; Eugenia Quiros-Roldan; Wilco Keulen; Luigia Scudeller; Sergio Lo Caputo; Charles Boucher; Francesco Castelli; Francesco Mazzotta; Piera Pierotti; Anne Mieke Been-Tiktak; Giovanni Buccoliero; Michele De Gennaro; Giampiero Carosi; Carmine Tinelli
Journal:  J Infect Dis       Date:  2003-07-01       Impact factor: 5.226

9.  Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.

Authors:  Martin S Hirsch; Huldrych F Günthard; Jonathan M Schapiro; Françoise Brun-Vézinet; Bonaventura Clotet; Scott M Hammer; Victoria A Johnson; Daniel R Kuritzkes; John W Mellors; Deenan Pillay; Patrick G Yeni; Donna M Jacobsen; Douglas D Richman
Journal:  Clin Infect Dis       Date:  2008-07-15       Impact factor: 9.079

10.  Comparison of nine resistance interpretation systems for HIV-1 genotyping.

Authors:  Martin Stürmer; Hans Wilhelm Doerr; Schlomo Staszewski; Wolfgang Preiser
Journal:  Antivir Ther       Date:  2003-06
View more
  5 in total

1.  Predicting HIV treatment response in Romania - Comment.

Authors:  Maja Stanojević; Djordje Jevtović; Gordana Dragović
Journal:  Germs       Date:  2012-03-01

Review 2.  Milk-borne infections. An analysis of their potential effect on the milk industry.

Authors:  Revathi Dhanashekar; Sindhura Akkinepalli; Arvind Nellutla
Journal:  Germs       Date:  2012-09-01

3.  Cardiac involvement in HIV-positive patients.

Authors:  Efrat Daglan; Dan Yamin; Bogdana Manu; Anca Streinu-Cercel
Journal:  Germs       Date:  2013-03-01

4.  Potential impact of a free online HIV treatment response prediction system for reducing virological failures and drug costs after antiretroviral therapy failure in a resource-limited setting.

Authors:  Andrew D Revell; Gerardo Alvarez-Uria; Dechao Wang; Anton Pozniak; Julio S Montaner; H Clifford Lane; Brendan A Larder
Journal:  Biomed Res Int       Date:  2013-09-24       Impact factor: 3.411

5.  A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients.

Authors:  Kuteesa R Bisaso; Susan A Karungi; Agnes Kiragga; Jackson K Mukonzo; Barbara Castelnuovo
Journal:  BMC Med Inform Decis Mak       Date:  2018-09-04       Impact factor: 2.796

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.